Dipharma Francis

Dipharma Group is a global CDMO and a leading manufacturer of APIs and Intermediates for generic and contract manufacturing markets, offering about 40 APIs with DMFs lodged worldwide, with more than 500 skilled and highly committed employees, 4 cGMP plants, located in the U.S.A. and Italy, plus commercial sales offices in Italy, the U.S.A. and China. 

Its fully equipped R&D Centres develop innovative chemical processes and crystalline forms for the most prominent pharmaceutical companies worldwide. 
Since 1970, Dipharma has managed to achieve a positive unbroken record of inspections by the major Regulatory Agencies and its cGMP manufacturing sites are equipped to supply quantities from laboratory to industrial scale, covering the entire lifecycle of a pharmaceutical substance.  

Dipharma's core technologies are: High-pressure hydrogenation, Nitration, Nitroesterification, Azide chemistry, Borane reductions, Cross-coupling reactions, Curtius reaction, Dissolving metal reduction, Enzymatic chemistry, Epichlorohydrin chemistry, Hoffman reaction, Hydrogen peroxide oxidations, Carbohydrate chemistry, Enantioselective reactions, Use of nitroalkanes (Henry reaction), Wolff-Kishner reduction

Dipharma Group has the right size and variety of scale-up capabilities to act as a global player and manage processes efficiently, while offering flexibility and agility to promptly solve any challenge. 

Experience you can trust